TRPS1 Polyclonal | IHC
| Test Details | Used to aid in the identification of triple negative metastatic carcinoma of breast origin. |
| Components | Performed as an LDT on Ventana Ultra platform |
| Methodology | Immunohistochemistry |
| Performed | Monday – Friday |
| Turnaround | 2 – 3 business days |
| Specimen Requirements | For Ventana IHC, sections should be on Plus(+) slides. Minimum of specimen requirement: 2 slides. If requesting interpretation, please submit an H&E slide. |
| Storage/Transport | Room temperature (use cold packs for transport of blocks during summer months) |
| CPT Code(s) | 88342 |
| Miscellaneous | This test was developed and its performance characteristics determined by AMP Core Labs (LDT). It has not been cleared or approved by the FDA. The laboratory is regulated under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes. It should not be regarded as investigational or for research. |